Combination therapy with estrogen and spironolactone may help some transgender women achieve desired results. We used two databases, OptumLabs® Data Warehouse (OLDW) and Veterans Health Administration (VHA), to examine trends in feminizing therapy. We included 3368 transgender patients from OLDW and 3527 from VHA, all of whom received estrogen, spironolactone, or both between 2006 and 2017. In OLDW, the proportion receiving combination therapy increased from 47% to 75% during this period. Similarly, in VHA, the proportion increased from 39% to 69% during this period. We conclude that the use of combination hormone therapy has become much more common over the past decade.
Get full access to this article
View all access options for this article.
References
1.
JamesSE, HermanJL, RankinS, et al.The Report of the 2015 U.S. Transgender Survey. Washington, DC: National Center for Transgender Equality, 2016.
2.
TuckerRP, TestaRJ, SimpsonTL, et al.Hormone therapy, gender affirmation surgery, and their association with recent suicidal ideation and depression symptoms in transgender veterans. Psychol Med. 2017; 48:2329–2336.
3.
HembreeWC, Cohen-KettenisPT, GoorenL, et al.Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2017; 102:3869–3903.
4.
SaferJD, TangprichaV. Care of transgender persons. N Engl J Med. 2019; 381:2451–2460.
5.
PriorJC, VignaYM, WatsonD. Spironolactone with physiological female steroids for presurgical therapy of male-to-female transsexualism. Arch Sex Behav. 1989; 18:49–57.
6.
CabanaMD, RandCS, PoweNR, et al.Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999; 282:1458–1465.
7.
CahillSR, BakerK, DeutschMB, et al.Inclusion of sexual orientation and gender identity in stage 3 meaningful use guidelines: a huge step forward for LGBT health. LGBT Health. 2016; 3:100–102.
8.
JasujaGK, de GrootA, QuinnEK, et al.Beyond gender identity disorder diagnoses codes: an examination of additional methods to identify transgender individuals in administrative databases. Med Care. 2020; 58:903–911.
9.
BlosnichJR, CashyJ, GordonAJ, et al.Using clinician text notes in electronic medical record data to validate transgender-related diagnosis codes. J Am Med Inform Assoc. 2018; 25:905–908.
10.
WolfeHL, ReismanJI, YoonS, et al.Validating data-driven methods to identify transgender individuals in the Veterans Affairs. Am J Epidemiol. 2021. [Epub ahead of print]; DOI: 10.1093/aje/kwab102.
11.
OptumLabs. OptumLabs and OptumLabs Data Warehouse (OLDW) Descriptions and Citation. Eden Prairie, MN: July 2020. PDF. Reproduced with permission from OptumLabs.
12.
AghaZ, LofgrenRP, VanRuiswykJV, LaydePM. Are patients at Veterans Affairs medical centers sicker? A comparative analysis of health status and medical resource use. Arch Intern Med. 2000; 160:3252–3257.
13.
HollenbachAD, EckstrandKL, DregerAD. Implementing Curricular and Institutional Climate Changes to Improve Health Care for Individuals Who Are LGBT, Gender Nonconforming, or Born with DSD: a Resource for Medical Educators. Washington, DC: Association of American Medical Colleges, 2014.
14.
KauthMR, ShipherdJC. Transforming a system: improving patient-centered care for sexual and gender minority veterans. LGBT Health. 2016; 3:177–179.
15.
World Professional Association for Transgender Health PracticeGuidelines, Version 7. Standards of Care for the Health of Transsexual, Transgender, and Gender Nonconforming People. Int J Transgend. 2012; 13:165–232.
16.
DeutchMB, ed. Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People, 2nd ed. Center of Excellence for Transgender Health, University of California, San Francisco, 2016.
17.
Transgender Cross-Sex Hormone Therapy Use. VA Pharmacy Benefits Management Services. Issued in 2011 and updated February, 2012. Available at: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwiggpeuq5f0AhXRgv0HHZIxBaEQFnoECAkQAQ&url=https%3A%2F%2Fwww.pbm.va.gov%2Fclinicalguidance%2Fclinicalrecommendations%2Ftransgendercarecrosssexhormonetherapyfeb2012.doc&usg=AOvVaw0Rh9TjAbPr422ZwtljX50z Accessed November14, 2021.
18.
VHA Directive 1341(2). Providing Health Care for Transgender and Intersex Veterans. May 23, 2018. Amended June 26, 2020. Available at: https://www.va.gov/vhapublications/ViewPublication.asp?pub_ID=6431 Accessed November14, 2021.
